Obinutuzumab (GA101) is highly effective against chronic lymphocytic leukemia cells in ex vivo B-cell depletion irrespective of high-risk prognostic markers.
作者信息
Ysebaert L, Laprévotte E, Klein C, Quillet-Mary A
机构信息
CRCT, UMR1037 Inserm-University, Toulouse III Paul Sabatier-ERL5294 CNRS, Toulouse, France.
Department of Haematology, Institut Universitaire du Cancer de Toulouse, Toulouse, France.
出版信息
Blood Cancer J. 2015 Nov 13;5(11):e367. doi: 10.1038/bcj.2015.93.
Abstract
摘要
Zotero 插件